Excerpt from CyclosporiasisSynonyms, Key Words, and Related Terms: blue-green algae, coccidian-like body, Cyanobacterium infection, Cyclospora cayetanensis, C cayetanensis, cyclosporiasis, diarrhea, GI infection, large Cryptosporidium infection, parasite, parasitic infection, acquired immunodeficiency syndrome, AIDS, chronic diarrhea, gastroenteritis, biliary disease Please click here to view the full topic text: CyclosporiasisBackgroundCyclospora cayetanensis is a coccidian parasite that infects the GI tract of both immunocompetent and immunocompromised hosts. This organism was first described in human feces in 1979. Since the advent of the acquired immunodeficiency syndrome (AIDS) epidemic, C cayetanensis has been increasingly recognized as an enteric pathogen.1 Cyclospora species are ubiquitous and infect various animals, including vipers, moles, rodents, and myriapods. Humans are the only known hosts of C cayetanensis. The first known outbreak of cyclosporiasis in the United States occurred in 1990 in a Chicago hospital's physicians' dormitory and was attributed to an infected water source. In 1996-97, US epidemics of cyclosporiasis were attributed to infected Guatemalan raspberries,2, 3 basil, and mesclun lettuce.4, 5, 6, 7 An outbreak resulted from exposure to contaminated berries at a social function in Ontario, Canada in 1999. More recent outbreaks have been associated with imported Thai basil8 and snow peas in a cluster of infections in Pennsylvania in 2004.9, 10 Otherwise, only sporadic cases, primarily involving travelers, have been documented. PathophysiologyCyclospora species are variably acid-fast, round-to-ovoid organisms that measure 8-10 µm in diameter. Cyclospora species exogenously sporulate and have 2 sporocysts per oocyst. Transmission follows ingestion of oocysts in fecally contaminated water or produce. Direct person-to-person transmission is considered unlikely because the oocysts are not infectious when excreted; the oocysts undergo sporulation outside the human host before becoming infective. The median incubation period is 1 week, during which time the organism invades enterocytes of the small intestine. Disease manifests as protracted and relapsing gastroenteritis. Cyclospora species are characterized by an anterior polar complex that allows penetration into host cells, but the life cycle of the parasite and the mechanisms by which it interacts with human host target cells to cause disease are poorly understood. FrequencyUnited StatesThe frequency of cyclosporiasis is unknown. InternationalMost fecal isolates have been obtained from residents of developing countries or from travelers returning from these regions. Cyclosporiasis is endemic in Haiti, Nepal, and Peru, with a strong seasonal predominance during rainy spring and summer months. Cyclosporiasis has also been reported in travelers returning from Mexico, Southeast Asia, Puerto Rico, Indonesia,11 Morocco, Pakistan, and India. Mortality/MorbidityDeath is exceptionally rare. Very little morbidity results from this infection, except in persons with underlying immunosuppression, in whom chronic diarrhea can develop. RaceNo racial predilection has been reported. SexCyclosporiasis equally affects both sexes. AgePersons of all ages can be affected, although cyclosporiasis primarily affects children in developing countries where the disease is endemic. Please click here to view the full topic text: Cyclosporiasis |
| About Us | Privacy | Code of Ethics | Terms of Use | Contact Us | Advertising | Institutional Subscribers |
|
|
|||
|
| Medicine is a constantly changing science and not all therapies are clearly established. New research changes drug and treatment therapies daily. The authors, editors, and publisher of this journal have used their best efforts to provide information that is up-to-date and accurate and is generally accepted within medical standards at the time of publication. However, as medical science is constantly changing and human error is always possible, the authors, editors, and publisher or any other party involved with the publication of this article do not warrant the information in this article is accurate or complete, nor are they responsible for omissions or errors in the article or for the results of using this information. The reader should confirm the information in this article from other sources prior to use. In particular, all drug doses, indications, and contraindications should be confirmed in the package insert. FULL DISCLAIMER |